{
    "2018-02-16": [
        [
            {
                "time": "2018-01-02",
                "original_text": "GlaxoSmithKline’s Revenues in 4Q17 Rose 1% Year-over-Year",
                "features": {
                    "keywords": [
                        "revenues",
                        "rose",
                        "year-over-year"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "How Cosentyx Resolves Enthesitis in Psoriatic Arthritis Patients",
                "features": {
                    "keywords": [
                        "cosentyx",
                        "resolves",
                        "enthesitis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Novartis’s Cosentyx May Emerge as a Leading Psoriasis Drug",
                "features": {
                    "keywords": [
                        "novartis",
                        "cosentyx",
                        "leading",
                        "psoriasis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles",
                "features": {
                    "keywords": [
                        "novartis",
                        "sell",
                        "generic",
                        "pill",
                        "business"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Novartis’s Cosentyx Emerged as Multi-Blockbuster Therapy in 2017",
                "features": {
                    "keywords": [
                        "novartis",
                        "cosentyx",
                        "blockbuster",
                        "therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Novartis readies to auction U.S. generic pills business - sources",
                "features": {
                    "keywords": [
                        "novartis",
                        "auction",
                        "generic",
                        "pills",
                        "business"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Merck’s Human Vaccines Business in 4Q17",
                "features": {
                    "keywords": [
                        "merck",
                        "vaccines",
                        "business"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion",
                "features": {
                    "keywords": [
                        "roche",
                        "acquire",
                        "flatiron",
                        "health"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "How Did Pfizer’s Legacy Established Products Segment Perform in 2017?",
                "features": {
                    "keywords": [
                        "pfizer",
                        "legacy",
                        "products",
                        "segment",
                        "perform"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "The Swiss Stock Market Extends Recovery And Finishes Week With A Gain",
                "features": {
                    "keywords": [
                        "swiss",
                        "stock",
                        "market",
                        "recovery",
                        "gain"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}